A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 52,249 shares of JAZZ stock, worth $6.43 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
52,249
Previous 58,817 11.17%
Holding current value
$6.43 Million
Previous $7.84 Million 6.16%
% of portfolio
0.13%
Previous 0.13%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $852,000 - $1.05 Million
-6,568 Reduced 11.17%
52,249 $8.32 Million
Q3 2022

Nov 07, 2022

SELL
$126.59 - $161.18 $1.09 Million - $1.39 Million
-8,645 Reduced 12.81%
58,817 $7.84 Million
Q2 2022

Aug 09, 2022

SELL
$141.59 - $168.66 $586,607 - $698,758
-4,143 Reduced 5.79%
67,462 $10.5 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $5.01 Million - $6.21 Million
-38,619 Reduced 35.04%
71,605 $11.1 Million
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $120,828 - $146,835
-1,008 Reduced 0.91%
110,224 $14 Million
Q3 2021

Nov 09, 2021

SELL
$128.64 - $184.79 $938,171 - $1.35 Million
-7,293 Reduced 6.15%
111,232 $14.5 Million
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $747,653 - $870,022
4,667 Added 4.1%
118,525 $21.1 Million
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $1.07 Million - $1.23 Million
-7,093 Reduced 5.86%
113,858 $18.7 Million
Q4 2020

Feb 08, 2021

SELL
$140.71 - $165.05 $3.41 Million - $4 Million
-24,265 Reduced 16.71%
120,951 $20 Million
Q3 2020

Nov 09, 2020

SELL
$105.46 - $144.13 $2.98 Million - $4.07 Million
-28,273 Reduced 16.3%
145,216 $20.7 Million
Q2 2020

Aug 10, 2020

SELL
$95.68 - $121.88 $2.41 Million - $3.07 Million
-25,208 Reduced 12.69%
173,489 $19.1 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $1.44 Million - $2.51 Million
-16,457 Reduced 7.65%
198,697 $19.8 Million
Q4 2019

Feb 12, 2020

SELL
$117.65 - $153.73 $1.07 Million - $1.39 Million
-9,072 Reduced 4.05%
215,154 $32.1 Million
Q3 2019

Nov 08, 2019

SELL
$125.18 - $143.24 $540,402 - $618,367
-4,317 Reduced 1.89%
224,226 $28.7 Million
Q2 2019

Jul 25, 2019

BUY
$125.55 - $144.48 $12.4 Million - $14.2 Million
98,491 Added 75.73%
228,543 $32.6 Million
Q1 2019

May 08, 2019

BUY
$121.81 - $142.95 $661,915 - $776,790
5,434 Added 4.36%
130,052 $18.6 Million
Q4 2018

Feb 05, 2019

BUY
$115.94 - $166.74 $14.4 Million - $20.8 Million
124,618 New
124,618 $15.4 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.